INSM
INSMED Inc
Company overview
- Market capitalization
- $25.70B
- Employees
- 1,664
- Latest publication
- 2026-09-29
About INSMED Inc
Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory nontuberculous mycobacterial lung infections, as well as is in phase 3 clinical trial for the treatment of mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It also develops brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1(DPP1) that is in phase 3 clinical trial for the treatment of bronchiectasis; and in phase 2 clinical trial for the treatment of chronic rhinosinusitis without nasal polyps and hidradenitis suppurativa. In addition, the company is developing treprostinil palmitil inhalation powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil, which is in phase 3 clinical trial for the treatment of pulmonary hypertension associated with interstitial lung disease; and phase 2 clinical trial for the treatment of pulmonary arterial hypertension. Further, it develops INS1201, a microdystrophin adeno-associated virus gene replacement therapy which is in phase 1 clinical trial for the treatment of Duchenne muscular dystrophy, as well as it is also developing pre-clinical research programs for gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. In addition, it provides INS1148, monoclonal antibody targeting stem cell factor called SCF248 that is in phase-2 clinical trial for the treatment of interstitial lung disease, and asthma; and INS1202, an intrathecally delivered gene therapy which is in phase 1 of clinical trial for the treatment of amyotrophic lateral sclerosis. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q3 20182018-09-30 · USD | Q2 20182018-06-30 · USD | Q1 20182018-03-31 · USD | Q4 20172017-12-31 · USD | Q3 20172017-09-30 · USD | Q2 20172017-06-30 · USD | Q1 20172017-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 425,486,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 67,212,000USD | 24,146,000USD | 21,395,000USD | 17,382,000USD | 21,647,000USD | 16,561,000USD | 17,232,000USD | 12,588,000USD |
| Gross Profit | 358,274,000USD | -24,146,000USD | -21,395,000USD | -17,382,000USD | -21,647,000USD | -16,561,000USD | -17,232,000USD | -12,588,000USD |
| Research Development | 210,034,000USD | 39,538,000USD | 35,722,000USD | 30,098,000USD | 33,949,000USD | 26,675,000USD | 26,871,000USD | 22,254,000USD |
| Selling General Administrative | 247,467,000USD | 44,445,000USD | 37,160,000USD | 32,653,000USD | 18,885,000USD | 9,355,000USD | 9,355,000USD | 8,654,000USD |
| Total Operating Expenses | 359,822,000USD | 83,983,000USD | 72,882,000USD | 62,751,000USD | 65,353,000USD | 44,083,000USD | 43,515,000USD | 35,969,000USD |
| Operating Income | -1,548,000USD | -83,983,000USD | -72,882,000USD | -62,751,000USD | -65,353,000USD | -44,083,000USD | -43,515,000USD | -35,969,000USD |
| Total Other Income Expense Net | -9,825,000USD | -3,714,000USD | -3,515,000USD | -5,725,000USD | -397,000USD | -1,069,000USD | -1,120,000USD | -1,415,000USD |
| Interest Expense | 20,273,000USD | 6,675,000USD | 6,488,000USD | 5,642,000USD | 1,466,000USD | 1,496,000USD | 1,489,000USD | 1,474,000USD |
| Income Before Tax | -11,373,000USD | -87,697,000USD | -76,397,000USD | -68,476,000USD | -65,750,000USD | -45,152,000USD | -44,635,000USD | -37,384,000USD |
| Income Tax Expense | 1,869,000USD | 46,000USD | 40,000USD | 48,000USD | -366,000USD | 27,000USD | 37,000USD | 30,000USD |
| Net Income | -13,242,000USD | -87,743,000USD | -76,437,000USD | -68,524,000USD | -65,384,000USD | -45,179,000USD | -44,672,000USD | -37,414,000USD |
| Net Income From Continuing Ops | — | -87,743,000USD | -76,437,000USD | -68,524,000USD | -65,384,000USD | -45,179,000USD | -44,672,000USD | -37,414,000USD |
| Ebit | — | -81,437,000USD | -70,195,000USD | -63,183,000USD | -64,284,000USD | -43,850,000USD | -43,146,000USD | -36,112,000USD |
| Ebitda | — | -80,483,000USD | -69,266,000USD | -62,414,000USD | -63,551,000USD | -43,136,000USD | -42,408,000USD | -35,396,000USD |
| Depreciation And Amortization | — | 954,000USD | 929,000USD | 769,000USD | 733,000USD | 714,000USD | 738,000USD | 716,000USD |
| Reconciled Depreciation | — | 954,000USD | 929,000USD | 769,000USD | 733,000USD | 714,000USD | 738,000USD | 716,000USD |
| Non Operating Income Net Other | — | 2,961,000USD | 2,973,000USD | -83,000USD | 1,069,000USD | 427,000USD | 369,000USD | 59,000USD |
| Minority Interest | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Discontinued Operations | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Net Income Applicable To Common Shares | — | -87,743,000USD | -76,437,000USD | -68,524,000USD | -65,384,000USD | -45,179,000USD | -44,672,000USD | -37,414,000USD |
| Unclassified Operating Expenses | — | — | — | — | 12,519,000USD | 8,053,000USD | 7,289,000USD | 5,061,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD | FY 20132013-12-31 · USD | FY 20122012-12-31 · USD | FY 20102010-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 9,835,000USD | 0USD | 0USD | 0USD | 11,500,000USD | 11,500,000USD | 0USD | 6,921,000USD |
| Cost Of Revenue | 2,423,000USD | 2,901,000USD | 2,438,000USD | 1,982,000USD | 33,535,000USD | 29,644,000USD | 21,369,000USD | 10,159,000USD |
| Gross Profit | 7,412,000USD | -2,901,000USD | -2,438,000USD | -1,982,000USD | -22,035,000USD | -18,144,000USD | -21,369,000USD | 6,921,000USD |
| Research Development | 145,283,000USD | 109,749,000USD | 122,721,000USD | 74,277,000USD | 56,292,000USD | 44,279,000USD | 29,781,000USD | 4,702,000USD |
| Selling General Administrative | 168,218,000USD | 79,171,000USD | 50,679,000USD | 43,216,000USD | 31,073,000USD | 18,627,000USD | 12,657,000USD | 10,311,000USD |
| Total Operating Expenses | 314,750,000USD | 188,920,000USD | 173,400,000USD | 117,493,000USD | 87,365,000USD | 66,515,000USD | 42,438,000USD | 15,013,000USD |
| Operating Income | -307,338,000USD | -188,920,000USD | -173,400,000USD | -117,493,000USD | -87,365,000USD | -55,015,000USD | -42,438,000USD | -8,092,000USD |
| Interest Income | 15,131,000USD | 4,301,000USD | 2,894,000USD | 2,628,000USD | — | — | — | — |
| Interest Expense | 25,472,000USD | 5,925,000USD | 3,498,000USD | 2,889,000USD | 2,415,000USD | 2,412,000USD | 763,000USD | 109,000USD |
| Net Interest Income | -25,472,000USD | -5,925,000USD | -3,498,000USD | — | — | — | — | — |
| Income Before Tax | -324,076,000USD | -192,921,000USD | -176,175,000USD | -120,154,000USD | -89,581,000USD | -57,294,000USD | -41,374,000USD | -6,356,000USD |
| Income Tax Expense | 201,000USD | -272,000USD | 98,000USD | -1,971,000USD | -10,422,000USD | -1,221,000USD | 763,000USD | 78,000USD |
| Tax Provision | 201,000USD | -272,000USD | 98,000USD | -1,971,000USD | — | — | — | — |
| Net Income | -324,277,000USD | -192,649,000USD | -176,273,000USD | -118,183,000USD | -79,159,000USD | -56,073,000USD | -41,374,000USD | -6,434,000USD |
| Net Income From Continuing Ops | -324,277,000USD | -192,649,000USD | -176,273,000USD | -118,183,000USD | -79,159,000USD | -56,073,000USD | -41,374,000USD | — |
| Ebit | -300,004,000USD | -186,996,000USD | -172,677,000USD | -117,265,000USD | -87,166,000USD | -54,882,000USD | -40,611,000USD | -6,247,000USD |
| Ebitda | -295,178,000USD | -184,095,000USD | -170,239,000USD | -115,283,000USD | -86,093,000USD | -54,202,000USD | -40,050,000USD | -6,193,000USD |
| Depreciation And Amortization | 4,826,000USD | 2,901,000USD | 2,438,000USD | 1,982,000USD | 1,073,000USD | 680,000USD | 561,000USD | 54,000USD |
| Reconciled Depreciation | 4,826,000USD | 2,901,000USD | — | — | — | — | — | — |
| Total Other Income Expense Net | -16,738,000USD | -4,001,000USD | -2,775,000USD | -2,661,000USD | -2,216,000USD | -2,279,000USD | -1,136,000USD | 1,736,000USD |
| Non Operating Income Net Other | 8,734,000USD | 1,924,000USD | 723,000USD | 228,000USD | 199,000USD | 133,000USD | 1,827,000USD | — |
| Net Income Applicable To Common Shares | -324,277,000USD | -192,649,000USD | -176,273,000USD | -118,183,000USD | -79,159,000USD | -56,073,000USD | -41,374,000USD | — |
| Unclassified Operating Expenses | — | — | — | — | — | 3,609,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 2,102,565,000USD | 2,075,862,999USD | 2,264,558,000USD | 2,360,736,000USD | 2,479,857,000USD | 1,802,735,000USD | 2,025,231,000USD | 2,052,972,000USD |
| Cash And Equivalents | 544,765,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 1,160,312,000USD | 1,223,514,000USD | 1,430,047,000USD | 1,679,986,000USD | 1,856,765,000USD | 1,199,451,000USD | 1,433,826,000USD | 1,467,908,000USD |
| Short Term Investments | 615,547,000USD | 641,326,000USD | 919,602,000USD | 1,345,222,000USD | 572,441,000USD | 796,204,000USD | 878,796,000USD | 1,006,457,000USD |
| Total Current Assets | 1,633,919,000USD | 1,613,173,000USD | 1,794,208,000USD | 1,931,807,000USD | 2,081,580,000USD | 1,402,692,000USD | 1,621,661,000USD | 1,649,845,000USD |
| Other Current Assets | 115,898,000USD | 78,195,000USD | 91,236,000USD | 65,597,000USD | 62,177,000USD | 54,782,000USD | 37,245,000USD | 41,150,000USD |
| Total Liabilities | 1,345,071,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 438,744,000USD | 361,008,000USD | 468,874,000USD | 417,214,000USD | 311,681,000USD | 239,233,000USD | 297,528,000USD | 259,188,000USD |
| Other Non Current Liabilities | 5,868,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 757,494,000USD | 704,852,000USD | 738,976,000USD | 945,571,000USD | 1,249,735,000USD | 99,159,000USD | 285,379,000USD | 483,415,000USD |
| Total Equity Including Noncontrolling Interest | 757,494,000USD | — | — | — | — | — | — | — |
| Long Term Debt | 543,513,000USD | 542,215,000USD | 540,964,000USD | 539,719,000USD | 538,508,000USD | 1,105,068,000USD | 1,103,382,000USD | 954,831,000USD |
| Net Receivables | 215,325,000USD | 178,555,000USD | 140,857,000USD | 65,259,000USD | 55,033,000USD | 47,746,000USD | 52,012,000USD | 42,317,000USD |
| Inventory | 142,384,000USD | 132,908,999USD | 132,068,000USD | 120,965,000USD | 107,605,000USD | 100,713,000USD | 98,578,000USD | 98,470,000USD |
| Property Plant Equipment Net | 120,398,000USD | 131,733,000USD | 139,211,000USD | 116,618,000USD | 117,227,000USD | 116,785,000USD | 115,582,000USD | 110,246,000USD |
| Goodwill | 136,110,000USD | — | — | — | — | — | — | — |
| Accounts Payable | 74,555,000USD | 73,380,000USD | 79,907,000USD | 79,591,000USD | 74,054,000USD | 57,683,000USD | 73,033,000USD | 64,950,000USD |
| Short Term Debt | 6,266,000USD | 14,426,000USD | 19,263,000USD | 12,320,000USD | 10,958,000USD | 10,271,000USD | 16,495,999USD | 14,227,000USD |
| Common Stock | 2,183,000USD | 2,165,000USD | 2,143,000USD | 2,126,000USD | 2,111,000USD | 1,819,000USD | 1,794,000USD | 1,788,000USD |
| Retained Earnings | -5,813,497,000USD | -5,800,255,000USD | -5,636,692,000USD | -5,308,207,000USD | -4,938,186,000USD | -4,616,500,000USD | -4,359,917,000USD | -4,124,369,000USD |
| Accumulated Other Comprehensive Income | -3,373,000USD | 4,000USD | 1,461,000USD | 1,998,000USD | 1,732,000USD | -902,000USD | -2,289,000USD | 547,000USD |
| Intangible Assets | — | 95,570,000USD | 97,651,000USD | 84,588,000USD | 56,126,000USD | 57,389,000USD | 58,652,000USD | 59,915,000USD |
| Total Liab | — | 1,371,011,000USD | 1,525,582,000USD | 1,415,165,000USD | 1,230,122,000USD | 1,703,576,000USD | 1,739,852,000USD | 1,569,557,000USD |
| Other Current Liab | — | 273,202,000USD | 369,704,000USD | 325,303,000USD | 226,669,000USD | 171,279,000USD | 207,999,000USD | 180,011,000USD |
| Capital Stock | — | 2,165,000USD | 2,143,000USD | 2,126,000USD | 2,111,000USD | 1,819,000USD | 1,794,000USD | 1,788,000USD |
| Good Will | — | 136,110,000USD | 136,110,000USD | 136,110,000USD | 136,110,000USD | 136,110,000USD | 136,110,000USD | 136,110,000USD |
| Cash | — | 582,188,000USD | 510,445,000USD | 334,764,000USD | 1,284,324,000USD | 403,247,000USD | 555,030,000USD | 461,451,000USD |
| Net Debt | — | 166,247,000USD | 257,714,000USD | 410,312,000USD | -540,986,000USD | 906,346,000USD | 759,091,000USD | 702,189,000USD |
| Short Long Term Debt Total | — | 748,435,000USD | 768,159,000USD | 745,076,000USD | 743,338,000USD | 1,309,593,000USD | 1,314,121,000USD | 1,163,640,000USD |
| Property Plant Equipment Gross | — | 195,326,000USD | 199,966,000USD | 173,813,000USD | 172,022,000USD | 169,026,000USD | 165,888,000USD | 159,186,000USD |
| Common Stock Shares Outstanding | — | 215,468,000shares | 213,637,000shares | 211,441,000shares | 189,302,000shares | 180,860,000shares | 179,021,000shares | 173,721,000shares |
| Non Current Assets Total | — | 462,689,999USD | 470,350,000USD | 428,929,000USD | 398,277,000USD | 400,043,000USD | 403,570,000USD | 403,127,000USD |
| Non Current Liabilities Total | — | 1,010,002,999USD | 1,056,708,000USD | 997,951,000USD | 918,441,000USD | 1,464,343,000USD | 1,442,324,000USD | 1,310,369,000USD |
| Non Current Liabilities Other | — | 438,131,000USD | 482,851,000USD | 429,049,000USD | 349,595,000USD | 327,529,000USD | 305,766,000USD | 321,005,000USD |
| Non Currrent Assets Other | — | 99,276,999USD | 97,378,000USD | 91,613,000USD | 88,814,000USD | 89,759,000USD | 93,226,000USD | 96,856,000USD |
| Net Working Capital | — | 1,252,165,000USD | 1,325,334,000USD | 1,514,593,000USD | 1,769,899,000USD | 1,163,459,000USD | 1,324,133,000USD | 1,390,657,000USD |
| Unclassified Non Current Liabilities | — | 29,656,999USD | 32,893,000USD | 29,183,000USD | 30,338,000USD | 31,746,000USD | 33,176,000USD | 34,533,000USD |
| Unclassified Equity | — | 6,500,773,000USD | 6,369,921,000USD | 6,247,528,000USD | 6,181,967,000USD | 4,712,923,000USD | 4,643,997,000USD | 4,603,661,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | -12,319,000USD | -14,227,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 2,264,558,000USD | 2,025,231,000USD | 1,329,837,000USD | 1,656,435,000USD | 1,243,508,000USD | 796,155,000USD | 742,299,000USD | 604,556,000USD |
| Intangible Assets | 97,651,000USD | 58,652,000USD | 63,704,000USD | 68,756,000USD | 73,809,000USD | 49,261,000USD | 53,682,000USD | 58,675,000USD |
| Other Current Assets | 91,236,000USD | 37,245,000USD | 24,179,000USD | 25,468,000USD | 28,898,000USD | 23,982,000USD | 20,220,000USD | 11,327,000USD |
| Total Liab | 1,525,582,000USD | 1,739,852,000USD | 1,661,760,000USD | 1,568,484,000USD | 833,040,000USD | 520,271,000USD | 480,625,000USD | 396,290,000USD |
| Total Stockholder Equity | 738,976,000USD | 285,379,000USD | -331,923,000USD | 87,951,000USD | 410,468,000USD | 275,884,000USD | 261,674,000USD | 208,266,000USD |
| Other Current Liab | 369,704,000USD | 207,999,000USD | 149,594,000USD | 131,656,000USD | 89,246,000USD | 63,398,000USD | 59,795,000USD | 61,991,000USD |
| Common Stock | 2,143,000USD | 1,794,000USD | 1,480,000USD | 1,357,000USD | 1,187,000USD | 1,028,000USD | 897,000USD | 773,000USD |
| Capital Stock | 2,143,000USD | 1,794,000USD | 1,480,000USD | 1,357,000USD | 1,187,000USD | 1,028,000USD | 897,000USD | 773,000USD |
| Retained Earnings | -5,636,692,000USD | -4,359,917,000USD | -3,446,145,000USD | -2,696,578,000USD | -2,265,243,000USD | -1,830,589,000USD | -1,536,499,000USD | -1,282,162,000USD |
| Good Will | 136,110,000USD | 136,110,000USD | 136,110,000USD | 136,110,000USD | 136,110,000USD | 49,261,000USD | 53,682,000USD | 58,675,000USD |
| Cash | 510,445,000USD | 555,030,000USD | 482,374,000USD | 1,074,036,000USD | 716,782,000USD | 532,756,000USD | 487,429,000USD | 495,072,000USD |
| Cash And Short Term Investments | 1,430,047,000USD | 1,433,826,000USD | 780,447,000USD | 1,148,280,000USD | 716,782,000USD | 532,756,000USD | 487,429,000USD | 495,072,000USD |
| Total Current Assets | 1,794,208,000USD | 1,621,661,000USD | 929,063,000USD | 1,273,383,000USD | 837,040,000USD | 622,892,000USD | 555,194,000USD | 518,946,000USD |
| Total Current Liabilities | 468,874,000USD | 297,528,000USD | 225,629,000USD | 190,243,000USD | 135,166,000USD | 118,807,000USD | 85,240,000USD | 79,732,000USD |
| Net Debt | 257,714,000USD | 759,091,000USD | 721,620,000USD | 103,829,000USD | -104,514,000USD | -127,914,000USD | -90,391,000USD | -178,514,000USD |
| Short Term Debt | 19,263,000USD | 16,495,999USD | 10,642,000USD | 8,126,000USD | 10,136,000USD | 12,556,000USD | 12,261,000USD | — |
| Short Long Term Debt Total | 768,159,000USD | 1,314,121,000USD | 1,203,994,000USD | 1,177,865,000USD | 612,268,000USD | 404,842,000USD | 397,038,000USD | 316,558,000USD |
| Long Term Debt | 540,964,000USD | 1,103,382,000USD | 1,155,313,000USD | 1,125,250,000USD | 566,588,000USD | 356,318,000USD | 335,940,000USD | 316,558,000USD |
| Short Term Investments | 919,602,000USD | 878,796,000USD | 298,073,000USD | 74,244,000USD | 0USD | — | — | — |
| Net Receivables | 140,857,000USD | 52,012,000USD | 41,189,000USD | 29,713,000USD | 24,351,000USD | 16,562,000USD | 19,232,000USD | 5,515,000USD |
| Inventory | 132,068,000USD | 98,578,000USD | 83,248,000USD | 69,922,000USD | 67,009,000USD | 49,592,000USD | 28,313,000USD | 7,032,000USD |
| Accounts Payable | 79,907,000USD | 73,033,000USD | 65,393,000USD | 50,461,000USD | 35,784,000USD | 42,853,000USD | 13,184,000USD | 17,741,000USD |
| Property Plant Equipment Net | 139,211,000USD | 115,582,000USD | 104,386,000USD | 102,082,000USD | 95,516,000USD | 97,233,000USD | 113,109,000USD | 22,636,000USD |
| Property Plant Equipment Gross | 199,966,000USD | 165,888,000USD | 149,014,000USD | 102,082,000USD | 95,516,000USD | 97,233,000USD | 113,109,000USD | 22,636,000USD |
| Accumulated Other Comprehensive Income | 1,461,000USD | -2,289,000USD | -745,000USD | 756,000USD | 968,000USD | 193,000USD | -10,000USD | -9,000USD |
| Common Stock Shares Outstanding | 213,637,000shares | 164,043,000shares | 140,433,000shares | 123,035,000shares | 112,111,000shares | 97,605,000shares | 84,560,000shares | 76,889,000shares |
| Non Current Assets Total | 470,350,000USD | 403,570,000USD | 400,774,000USD | 383,052,000USD | 406,468,000USD | 173,263,000USD | 187,105,000USD | 85,610,000USD |
| Non Current Liabilities Total | 1,056,708,000USD | 1,442,324,000USD | 1,436,131,000USD | 1,378,241,000USD | 697,874,000USD | 401,464,000USD | 395,385,000USD | 316,558,000USD |
| Non Current Liabilities Other | 482,851,000USD | 305,766,000USD | 242,779,000USD | 208,502,000USD | 131,286,000USD | 45,146,000USD | 59,445,000USD | — |
| Non Currrent Assets Other | 97,378,000USD | 93,226,000USD | 96,574,000USD | 76,104,000USD | 50,990,000USD | 26,769,000USD | 20,314,000USD | 4,299,000USD |
| Net Working Capital | 1,325,334,000USD | 1,324,133,000USD | 703,434,000USD | 1,083,140,000USD | 701,874,000USD | 504,085,000USD | 469,954,000USD | 439,214,000USD |
| Unclassified Non Current Liabilities | 32,893,000USD | 33,176,000USD | 38,039,000USD | -53,586,000USD | -167,781,000USD | -56,467,000USD | -62,747,000USD | -56,988,000USD |
| Unclassified Equity | 6,369,921,000USD | 4,643,997,000USD | 3,112,007,000USD | 2,781,059,000USD | 2,672,369,000USD | 2,104,224,000USD | 1,796,389,000USD | 1,488,891,000USD |
| Current Deferred Revenue | — | -12,319,000USD | -65,393,000USD | — | — | — | 59,515,000USD | — |
| Deferred Long Term Liab | — | — | — | 37,588,000USD | 72,039,000USD | 47,289,000USD | 52,139,000USD | 56,988,000USD |
| Other Liab | — | — | — | 60,487,000USD | 95,742,000USD | 9,178,000USD | 10,608,000USD | — |
| Other Assets | — | — | — | 113,692,000USD | 50,990,000USD | 70,049,000USD | 72,453,000USD | 61,287,000USD |
| Long Term Investments | — | — | — | 0USD | 50,043,000USD | 0USD | — | — |
| Net Tangible Assets | — | — | — | -116,915,000USD | 200,549,000USD | 226,623,000USD | 207,992,000USD | 149,591,000USD |
| Unclassified Non Current Assets | — | — | — | -113,692,000USD | -50,990,000USD | -119,310,000USD | -126,135,000USD | -119,962,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | -59,515,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 10,275,000USD |
| Stock Based Compensation | 87,008,000USD |
| Deferred Income Tax | 0USD |
| Change To Account Receivables | -75,350,000USD |
| Change To Inventory | -14,860,000USD |
| Change To Liabilities | 33,704,000USD |
| Change In Working Capital | -89,142,000USD |
| Operating Cash Flow | -311,566,000USD |
| Capital Expenditures | -9,739,000USD |
| Net Investments | 314,772,000USD |
| Unclassified Investing Cash Flow | -15,000,000USD |
| Investing Cash Flow | 290,033,000USD |
| Net Debt Issuance | -1,626,000USD |
| Unclassified Financing Cash Flow | 58,319,000USD |
| Financing Cash Flow | 56,693,000USD |
| Effect Of Forex Changes On Cash | -840,000USD |
| Change In Cash | 34,320,000USD |
| End Cash Flow | 544,765,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -163,563,000USD | -328,485,000USD | -370,021,000USD | -321,686,000USD | -256,583,000USD | -235,548,000USD | -220,524,000USD | -300,609,000USD |
| Depreciation | 5,015,000USD | 5,561,000USD | 3,996,000USD | 3,747,000USD | 3,146,000USD | 2,741,000USD | 2,722,000USD | 2,699,000USD |
| Stock Based Compensation | 45,754,000USD | 39,039,000USD | 31,433,000USD | 42,976,000USD | 39,262,000USD | 26,554,000USD | 25,545,000USD | 23,286,000USD |
| Other Non Cash Items | -45,733,000USD | 112,971,000USD | 100,935,000USD | 59,856,000USD | 18,177,000USD | -17,848,000USD | 27,072,000USD | 112,111,000USD |
| Change To Account Receivables | -38,190,000USD | -77,300,000USD | -10,226,000USD | -6,142,000USD | 5,361,000USD | -11,817,000USD | -35,000USD | -4,035,000USD |
| Change To Inventory | -1,886,000USD | -11,764,000USD | -13,758,000USD | -4,976,000USD | -1,021,000USD | -2,122,000USD | -6,569,000USD | -7,755,000USD |
| Change In Working Capital | -64,211,000USD | -37,643,000USD | 13,896,000USD | 9,538,000USD | -66,090,000USD | 28,122,000USD | -15,731,000USD | 39,561,000USD |
| Total Cash From Operating Activities | -222,738,000USD | -247,596,000USD | -219,761,000USD | -205,569,000USD | -262,088,000USD | -195,979,000USD | -180,916,000USD | -122,952,000USD |
| Capital Expenditures | -3,480,000USD | -46,589,000USD | -2,418,000USD | -3,484,000USD | -10,070,000USD | -6,772,000USD | -3,689,000USD | -6,783,000USD |
| Free Cash Flow | -226,218,000USD | -294,185,000USD | -222,179,000USD | -209,053,000USD | -272,158,000USD | -202,751,000USD | -184,605,000USD | -129,735,000USD |
| Investments | 284,000,000USD | 436,000,000USD | -762,233,000USD | 227,835,000USD | 80,412,000USD | 131,758,000USD | -1,003,471,000USD | -6,783,000USD |
| Total Cashflows From Investing Activities | 265,520,000USD | 389,411,000USD | -762,233,000USD | 227,835,000USD | 80,412,000USD | 131,758,000USD | -1,003,471,000USD | -6,783,000USD |
| Net Borrowings | -799,000USD | -776,000USD | -747,000USD | -2,697,000USD | -706,000USD | 149,314,000USD | -658,000USD | — |
| Total Cash From Financing Activities | 29,514,000USD | 33,859,000USD | 33,410,000USD | 857,806,000USD | 28,998,000USD | 159,305,000USD | 397,200,000USD | 781,493,000USD |
| Change In Cash | 71,743,000USD | 175,681,000USD | -949,560,000USD | 881,077,000USD | -151,783,000USD | 93,579,000USD | -785,348,000USD | 651,070,000USD |
| Begin Period Cash Flow | 510,445,000USD | 334,764,000USD | 1,284,324,000USD | 403,247,000USD | 555,030,000USD | 461,451,000USD | 1,246,799,000USD | 595,729,000USD |
| End Period Cash Flow | 582,188,000USD | 510,445,000USD | 334,764,000USD | 1,284,324,000USD | 403,247,000USD | 555,030,000USD | 461,451,000USD | 1,246,799,000USD |
| Other Cashflows From Investing Activities | -15,000,000USD | — | — | — | — | — | — | — |
| Other Cashflows From Financing Activities | 29,514,000USD | — | 33,410,000USD | 35,000,000USD | 29,704,000USD | 157,393,000USD | 26,880,000USD | 782,138,000USD |
| Issuance Of Capital Stock | — | 0USD | -256,000USD | — | — | -12,000USD | 370,978,000USD | — |
| Unclassified Operating Cash Flow | — | -39,039,000USD | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | 34,635,000USD | 1,003,000USD | 825,503,000USD | — | -147,390,000USD | — | — |
| Unclassified Investing Cash Flow | — | — | — | 3,484,000USD | 10,070,000USD | 6,772,000USD | — | 6,783,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1,276,775,000USD | -913,772,000USD | -749,567,000USD | -481,534,000USD | -434,654,000USD | -294,090,000USD | -254,337,000USD | -324,277,000USD |
| Depreciation | 16,450,000USD | 11,013,000USD | 10,579,000USD | 10,331,000USD | 14,182,000USD | 14,150,000USD | 10,181,000USD | 4,826,000USD |
| Stock Based Compensation | 152,710,000USD | 96,835,000USD | 74,778,000USD | 57,686,000USD | 46,021,000USD | 36,158,000USD | 26,971,000USD | 26,240,000USD |
| Other Non Cash Items | 252,900,000USD | 125,219,000USD | 167,181,000USD | 6,503,000USD | 52,040,000USD | 27,388,000USD | 29,505,000USD | 17,289,000USD |
| Change To Account Receivables | -88,307,000USD | -12,932,000USD | -11,963,000USD | -6,423,000USD | -8,118,000USD | 2,670,000USD | -13,717,000USD | -5,515,000USD |
| Change To Inventory | -31,519,000USD | -17,044,000USD | -13,613,000USD | -1,714,000USD | -17,456,000USD | -21,180,000USD | -21,281,000USD | -7,032,000USD |
| Change In Working Capital | -80,299,000USD | -3,177,000USD | -39,218,000USD | 6,575,000USD | -58,580,000USD | -2,954,000USD | -62,969,000USD | 15,736,000USD |
| Total Cash From Operating Activities | -935,014,000USD | -683,882,000USD | -536,247,000USD | -400,439,000USD | -363,302,000USD | -219,348,000USD | -250,649,000USD | -257,977,000USD |
| Capital Expenditures | -32,561,000USD | -21,923,000USD | -13,288,000USD | -9,878,000USD | -7,289,000USD | -6,822,000USD | -42,268,000USD | -14,814,000USD |
| Free Cash Flow | -967,575,000USD | -705,805,000USD | -549,535,000USD | -410,317,000USD | -370,591,000USD | -226,170,000USD | -292,917,000USD | -272,791,000USD |
| Investments | -2,014,000USD | -583,175,000USD | -205,098,000USD | -34,584,000USD | -50,292,000USD | -6,822,000USD | -42,268,000USD | -14,814,000USD |
| Total Cashflows From Investing Activities | -64,575,000USD | -583,175,000USD | -223,604,000USD | -34,584,000USD | -64,285,000USD | -6,822,000USD | -42,268,000USD | -14,814,000USD |
| Net Borrowings | -4,926,000USD | 147,390,000USD | -1,217,000USD | 332,217,000USD | 321,704,000USD | -936,000USD | -936,000USD | 377,928,000USD |
| Total Cash From Financing Activities | 954,073,000USD | 1,341,020,000USD | 168,439,000USD | 793,273,000USD | 612,546,000USD | 271,003,000USD | 285,278,000USD | 386,743,000USD |
| Issuance Of Capital Stock | 823,282,000USD | 1,084,124,000USD | 296,784,000USD | 292,153,000USD | 269,886,000USD | 245,866,000USD | 261,074,000USD | 0USD |
| Change In Cash | -44,585,000USD | 72,656,000USD | -591,662,000USD | 357,254,000USD | 184,026,000USD | 45,327,000USD | -7,643,000USD | 113,907,000USD |
| Begin Period Cash Flow | 555,030,000USD | 482,374,000USD | 1,074,036,000USD | 716,782,000USD | 532,756,000USD | 487,429,000USD | 495,072,000USD | 381,165,000USD |
| End Period Cash Flow | 510,445,000USD | 555,030,000USD | 482,374,000USD | 1,074,036,000USD | 716,782,000USD | 532,756,000USD | 487,429,000USD | 495,072,000USD |
| Other Cashflows From Investing Activities | -30,000,000USD | — | 3,417,000USD | -24,706,000USD | -56,996,000USD | -582,000USD | — | -1,724,000USD |
| Unclassified Financing Cash Flow | 135,717,000USD | — | -144,309,000USD | — | -7,400,000USD | -25,137,000USD | -18,765,000USD | 14,237,000USD |
| Other Cashflows From Financing Activities | — | 109,506,000USD | 17,181,000USD | 151,721,000USD | 6,319,000USD | 25,137,000USD | 24,204,000USD | -14,237,000USD |
| Unclassified Investing Cash Flow | — | 21,923,000USD | -8,635,000USD | 34,584,000USD | 50,292,000USD | 7,404,000USD | 42,268,000USD | 16,538,000USD |
| Change To Liabilities | — | — | — | 50,011,000USD | -7,575,000USD | 24,931,000USD | -3,245,000USD | 33,797,000USD |
| Sale Purchase Of Stock | — | — | — | 311,657,000USD | 291,923,000USD | 271,939,000USD | 280,775,000USD | 8,815,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 358,250,000USD | 184,959,000USD | 45,327,000USD | -7,643,000USD | 113,907,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | 17,689,000USD | — | — | — |
| Exchange Rate Changes | — | — | — | — | — | 494,000USD | -4,000USD | -45,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Geography | International | 46,745,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | United States | 378,741,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | ARIKAYCE | 116,316,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | BRINSUPRI | 309,170,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | International | 35,898,000 | USD | 0001104506-26-000032 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 270,066,000 | USD | 0001104506-26-000032 |
| Q1 2026Quarterly · 2026-03-31 | Product | ARIKAYCE | 98,110,000 | USD | 0001104506-26-000032 |
| Q1 2026Quarterly · 2026-03-31 | Product | BRINSUPRI | 207,854,000 | USD | 0001104506-26-000032 |
| FY 2025Yearly · 2025-12-31 | Geography | International | 153,471,000 | USD | 0001104506-26-000009 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 452,952,000 | USD | 0001104506-26-000009 |
| FY 2025Yearly · 2025-12-31 | Product | ARIKAYCE | 433,765,000 | USD | 0001104506-26-000009 |
| FY 2025Yearly · 2025-12-31 | Product | BRINSUPRI | 172,658,000 | USD | 0001104506-26-000009 |
| Q3 2025Quarterly · 2025-09-30 | Geography | International | 40,307,000 | USD | 0001104506-25-000053 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 102,035,000 | USD | 0001104506-25-000053 |
| Q3 2025Quarterly · 2025-09-30 | Product | ARIKAYCE | 114,291,000 | USD | 0001104506-25-000053 |
| Q3 2025Quarterly · 2025-09-30 | Product | BRINSUPRI | 28,051,000 | USD | 0001104506-25-000053 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Europe And The Rest Of The World | 8,060,000 | USD | 0001104506-25-000043 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Japan | 30,672,000 | USD | 0001104506-25-000043 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 68,683,000 | USD | 0001104506-25-000043 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Europe And The Rest Of The World | 6,465,000 | USD | 0001104506-25-000026 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Japan | 22,083,000 | USD | 0001104506-25-000026 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 64,275,000 | USD | 0001104506-25-000026 |
| Q1 2025Quarterly · 2025-03-31 | Product | ARIKAYCE | 92,823,000 | USD | 0001104506-26-000032 |
| Q1 2025Quarterly · 2025-03-31 | Product | BRINSUPRI | 0 | USD | 0001104506-26-000032 |
| Q4 2024Quarterly · 2024-12-31 | Geography | Europe And The Rest Of The World | 5,938,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | Japan | 30,714,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | United States | 67,790,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Europe And The Rest Of The World | 21,208,000 | USD | 0001104506-25-000009 |
| FY 2024Yearly · 2024-12-31 | Geography | Japan | 87,699,000 | USD | 0001104506-25-000009 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 254,800,000 | USD | 0001104506-25-000009 |
| FY 2024Yearly · 2024-12-31 | Product | ARIKAYCE | 363,707,000 | USD | 0001104506-26-000009 |
| FY 2024Yearly · 2024-12-31 | Product | BRINSUPRI | 0 | USD | 0001104506-26-000009 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Europe And The Rest Of The World | 5,574,000 | USD | 0001104506-24-000033 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Japan | 20,983,000 | USD | 0001104506-24-000033 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 66,868,000 | USD | 0001104506-24-000033 |
| Q3 2024Quarterly · 2024-09-30 | Product | ARIKAYCE | 93,425,000 | USD | 0001104506-25-000053 |
| Q3 2024Quarterly · 2024-09-30 | Product | BRINSUPRI | 0 | USD | 0001104506-25-000053 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Europe And The Rest Of The World | 5,436,000 | USD | 0001104506-25-000043 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Japan | 21,111,000 | USD | 0001104506-25-000043 |
| Q2 2024Quarterly · 2024-06-30 | Geography | United States | 63,793,000 | USD | 0001104506-25-000043 |
| FY 2023Yearly · 2023-12-31 | Geography | Europe And The Rest Of The World | 15,280,000 | USD | 0001104506-25-000009 |
| FY 2023Yearly · 2023-12-31 | Geography | Japan | 65,733,000 | USD | 0001104506-25-000009 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 224,195,000 | USD | 0001104506-25-000009 |
| FY 2023Yearly · 2023-12-31 | Product | ARIKAYCE | 305,208,000 | USD | 0001104506-26-000009 |
| FY 2023Yearly · 2023-12-31 | Product | BRINSUPRI | 0 | USD | 0001104506-26-000009 |
| FY 2022Yearly · 2022-12-31 | Geography | Europe And The Rest Of The World | 2,858,000 | USD | 0001104506-25-000009 |
| FY 2022Yearly · 2022-12-31 | Geography | Japan | 56,506,000 | USD | 0001104506-25-000009 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 185,994,000 | USD | 0001104506-25-000009 |
| FY 2021Yearly · 2021-12-31 | Geography | Europe And The Rest Of The World | 12,945,000 | USD | 0001104506-23-000009 |
| FY 2021Yearly · 2021-12-31 | Geography | Japan | 16,006,000 | USD | 0001104506-23-000009 |
| FY 2021Yearly · 2021-12-31 | Geography | United States | 159,510,000 | USD | 0001104506-23-000009 |
| FY 2020Yearly · 2020-12-31 | Geography | Europe And The Rest Of The World | 6,893,000 | USD | 0001104506-22-000008 |
| FY 2020Yearly · 2020-12-31 | Geography | Japan | 0 | USD | 0001104506-22-000008 |
| FY 2020Yearly · 2020-12-31 | Geography | United States | 157,520,000 | USD | 0001104506-22-000008 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.